HUT77517A - Biciklusos tetrahidro-pirazolo-piridin-származékok, alkalmazásuk és ilyen vegyületeket tartalmazó gyógyászati készítmények - Google Patents

Biciklusos tetrahidro-pirazolo-piridin-származékok, alkalmazásuk és ilyen vegyületeket tartalmazó gyógyászati készítmények Download PDF

Info

Publication number
HUT77517A
HUT77517A HU9702289A HU9702289A HUT77517A HU T77517 A HUT77517 A HU T77517A HU 9702289 A HU9702289 A HU 9702289A HU 9702289 A HU9702289 A HU 9702289A HU T77517 A HUT77517 A HU T77517A
Authority
HU
Hungary
Prior art keywords
alkyl
carbon atoms
group
hydrogen
formula
Prior art date
Application number
HU9702289A
Other languages
English (en)
Hungarian (hu)
Inventor
Allen J. Duplantier
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of HUT77517A publication Critical patent/HUT77517A/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HU9702289A 1994-10-20 1995-10-06 Biciklusos tetrahidro-pirazolo-piridin-származékok, alkalmazásuk és ilyen vegyületeket tartalmazó gyógyászati készítmények HUT77517A (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32643494A 1994-10-20 1994-10-20

Publications (1)

Publication Number Publication Date
HUT77517A true HUT77517A (hu) 1998-05-28

Family

ID=23272184

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9702289A HUT77517A (hu) 1994-10-20 1995-10-06 Biciklusos tetrahidro-pirazolo-piridin-származékok, alkalmazásuk és ilyen vegyületeket tartalmazó gyógyászati készítmények

Country Status (16)

Country Link
EP (1) EP0787132A1 (cs)
JP (1) JPH09511758A (cs)
KR (1) KR970707124A (cs)
CN (1) CN1050129C (cs)
AU (1) AU702105B2 (cs)
BR (1) BR9504491A (cs)
CZ (1) CZ120097A3 (cs)
FI (1) FI954991A7 (cs)
HU (1) HUT77517A (cs)
IL (1) IL115667A0 (cs)
MX (1) MX9504422A (cs)
NO (1) NO971811L (cs)
NZ (1) NZ292991A (cs)
PL (1) PL319758A1 (cs)
WO (1) WO1996012720A1 (cs)
ZA (1) ZA958839B (cs)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP1147A (en) * 1996-05-03 2003-02-25 Pfizer Substituted indazole derivatives and related compounds.
JP4373497B2 (ja) * 1996-06-19 2009-11-25 ローン−プーラン・ロレ・リミテツド 置換されたアザビシクロ化合物、ならびにtnfおよびサイクリックampホスホジエステラーゼ産生の阻害剤としてのそれらの使用
AU716376B2 (en) * 1996-06-25 2000-02-24 Pfizer Inc. Substituted indazole derivatives and their use as phosphodiesterase (PDE) type IV and tumor necrosis factor (TNF) inhibitors
WO1998050367A1 (en) 1997-05-08 1998-11-12 Pfizer Products Inc. Processes and intermediates for preparing substituted indazole derivatives
IL126745A (en) * 1997-11-04 2003-09-17 Pfizer Prod Inc Methods of preparing 4-cyano-4- (substituted indazole) cyclohexanecarboxylic acids useful as pde4 inhibitors
HK1052508B (zh) * 1998-12-23 2008-08-01 Bristol-Myers Squibb Pharma Company 作为凝血因子xa抑制剂的含氮杂双环
US6858616B2 (en) 1998-12-23 2005-02-22 Bristol-Myers Squibb Pharma Company Nitrogen containing heterobicycles as factor Xa inhibitors
US6326495B2 (en) 1999-04-30 2001-12-04 Pfizer Inc. Process for preparing 8-cyclopentyl-6-ethyl-3-[substituted]-5,8-dihydro-4H-1,2,3a,7,8-pentaaza-as-indacenes and intermediates useful therein
ATE320800T1 (de) 1999-08-21 2006-04-15 Altana Pharma Ag Synergistische kombination von roflumilast und salmeterol
ES2349762T3 (es) * 2000-08-10 2011-01-11 Pfizer Italia S.R.L. Biciclo-pirazoles activos como inhibidores de quinasas, procedimientos para su preparación y composiciones farmacéuticas que los comprenden.
US6998408B2 (en) 2001-03-23 2006-02-14 Bristol-Myers Squibb Pharma Company 6-5, 6-6, or 6-7 Heterobicycles as factor Xa inhibitors
EP1379244A4 (en) 2001-04-18 2006-03-15 Bristol Myers Squibb Co 1,4,5,6-TETRAHYDROPYRAZOLO-3,4-C] -PYRIDINE-7-ONE AS FACTOR XA HEMMER
CA2444571A1 (en) 2001-04-18 2002-10-31 Bristol-Myers Squibb Company 1, 4, 5, 6-tetrahydropyrazolo-¬3, 4-c|-pyridin-7-ones as factor xa inhi bitors
JP4196678B2 (ja) 2001-04-26 2008-12-17 味の素株式会社 複素環化合物
TWI331526B (en) 2001-09-21 2010-10-11 Bristol Myers Squibb Pharma Co Lactam-containing compounds and derivatives thereof as factor xa inhibitors
CA2726702A1 (en) 2001-09-21 2003-04-03 Bristol-Myers Squibb Company Lactam-containing compounds and derivatives thereof as factor xa inhibitors
WO2004014374A1 (en) * 2002-07-25 2004-02-19 Pharmacia Italia S.P.A. Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
EA200501548A1 (ru) 2003-04-01 2006-02-24 Апплайд Резеч Системз Арс Холдинг Н.В. Ингибиторы фосфодиэстераз при бесплодии
AR045037A1 (es) * 2003-07-10 2005-10-12 Aventis Pharma Sa Tetrahidro-1h-pirazolo [3,4-c] piridinas sustituidas, composiciones que las contienen y su utilizacion.
FR2857363B1 (fr) * 2003-07-10 2007-09-07 Aventis Pharma Sa 4,5,6,7-tetrahydro-1h-pyrazolo[3,4-c] pyridines substituees compositions les contenant et utilisation
EP1957458A2 (en) * 2005-12-01 2008-08-20 Elan Pharmaceuticals Inc. 5-(arylsulfonyl)-pyrazolopiperidines
US8598195B2 (en) 2008-04-30 2013-12-03 Fredrik Almqvist Peptidomimetic compounds
US7741350B1 (en) 2009-01-28 2010-06-22 Cara Therapeutics, Inc. Bicyclic pyrazolo-heterocycles
KR101787116B1 (ko) 2009-01-28 2017-10-18 케러 테라퓨틱스, 인코포레이티드 바이시클릭 피라졸로-헤테로사이클
TW201613917A (en) 2014-06-06 2016-04-16 Biogen Ma Inc ATX modulating agents
CN115043768A (zh) * 2022-06-20 2022-09-13 新乡市润宇新材料科技有限公司 一种酸促进环丙基开环合成n-芳基吡咯烷-2-酮的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1463883A (fr) * 1964-09-08 1966-07-22 Ciba Geigy Procédé de préparation de triaza-composés bicycliques
US3340269A (en) * 1964-09-08 1967-09-05 Ciba Geigy Corp 1-substituted 4-acyl-2, 3-dioxo-piperidine
US3365459A (en) * 1964-09-08 1968-01-23 Ciba Geigy Corp Certain tetrahydro pyrazolo-pyridine and pyrazolo-piperidine derivatives
JP2944048B2 (ja) * 1993-07-06 1999-08-30 フアイザー・インコーポレイテツド 二環式テトラヒドロピラゾロピリジン

Also Published As

Publication number Publication date
AU702105B2 (en) 1999-02-11
MX9504422A (es) 1997-04-30
JPH09511758A (ja) 1997-11-25
NO971811D0 (no) 1997-04-18
CN1050129C (zh) 2000-03-08
WO1996012720A1 (en) 1996-05-02
KR970707124A (ko) 1997-12-01
NZ292991A (en) 1999-02-25
CZ120097A3 (cs) 1998-01-14
AU3531795A (en) 1996-05-15
EP0787132A1 (en) 1997-08-06
FI954991L (fi) 1996-04-21
ZA958839B (en) 1997-04-21
IL115667A0 (en) 1996-01-19
FI954991A0 (fi) 1995-10-19
FI954991A7 (fi) 1996-04-21
NO971811L (no) 1997-06-18
PL319758A1 (en) 1997-08-18
BR9504491A (pt) 1997-05-20
CN1161040A (zh) 1997-10-01

Similar Documents

Publication Publication Date Title
HUT77517A (hu) Biciklusos tetrahidro-pirazolo-piridin-származékok, alkalmazásuk és ilyen vegyületeket tartalmazó gyógyászati készítmények
RU2131876C1 (ru) Бициклические тетрагидропиразолпиридины или их фармацевтически приемлемые соли, фармацевтическая композиция, способ ингибирования фосфодиэстеразы, способ лечения
JP4426660B2 (ja) ピラゾール誘導体、その製法および医薬としてのその使用
KR0170567B1 (ko) 부신피질자극호르몬-유리 인자 길항물질 활성을 갖는 피라졸 및 피라졸로피리미딘
ES2218548T3 (es) Derivados de fenilo trisustituidos, utiles como inhibidores de la pde iv.
KR100339935B1 (ko) 치환된 인다졸 유도체, 및 포스포디에스테라제 4형 및 종양괴사 인자 형성의 억제제로서의 그의 용도
JP5092402B2 (ja) ピラゾロピリジン誘導体
WO2004035588A1 (en) Pyradazine compounds as gsk-3 inhibitors
JPH08269060A (ja) ヘテロ環化合物、その製造方法およびそれを含有する医薬品
CZ11996A3 (en) Tri-substituted imidazoles, process of their preparation, intermediates of the process, pharmaceutical preparation and the use of the compounds for various therapeutical applications
CN106660996B (zh) 作为pde4抑制剂的2,5-取代的嘧啶类
KR20000022516A (ko) 치환된 인다졸 유도체 및 포스포디에스테라제 4형 및 종양 괴사인자 억제제로서 그의 용도
WO1997047622A1 (en) Cytokine production inhibitors, triazepine compounds, and intermediates thereof
JP3032840B2 (ja) 置換インダゾール誘導体
JP2013505220A (ja) P2x7調節薬としての縮合トリアゾールアミン類
JP2006514110A (ja) Ip受容体アンタゴニストとしてのフェニルまたはヘテロアリールアミノアルカン誘導体
US7795256B2 (en) Thieno-pyridinone derivatives as kinase inhibitors
PL184195B1 (pl) Nowe 5,6-dihydro-9H-pirazolo [3,4-c]-1,2,4-triazolo [4,3-a] pirydyny i środek farmaceutyczny
WO1991017162A1 (en) Imidazopyridine paf antagonists
FR2566404A1 (fr) Nouveaux derives de la 1,4-dihydropyridine, leurs sels, procede pour les preparer, et compositions pharmaceutiques les contenant
HU198199B (en) Process for production of derivatives of imidasolidinon and medical compositions containing these substances
AU2004263278B2 (en) N-[3-(3-substituted-pyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-sulfonamides, and compositions, and methods related thereto
DK169517B1 (da) [Aryl](3-pyridinyl)methanon,oximderivater samt fremgangsmåde til fremstilling deraf
US6140325A (en) Thienopyrimidine derivatives, their production and use
US20050159444A1 (en) Bicyclic unsaturated tertiary amine compounds

Legal Events

Date Code Title Description
DFC4 Cancellation of temporary protection due to refusal